山東華鵬(603021.SH):選舉胡磊為公司第七屆董事會董事長
格隆匯2月9日丨山東華鵬(603021.SH)公佈,公司於2022年2月9日召開第七屆董事會第二十八次會議,審議通過了《關於選舉公司董事長暨變更法定代表人的議案》。根據《公司法》和《公司章程》相關規定,公司董事會選舉胡磊為公司第七屆董事會董事長,任期與公司第七屆董事會任期一致。同時,公司獨立董事就選舉公司董事長暨變更法定代表人發表了同意的獨立意見。
根據《公司章程》的規定,公司董事長為公司的法定代表人,因此公司法定代表人將變更為胡磊,同時,公司董事會授權經營層辦理法定代表人變更的相關事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.